在一个大型学术医疗中心实施血液静止产品的成本和变化减少计划:多利益相关者视角
Tejen Shah1, Stacy Brethauer1, Walter A Danker2
1Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
Medical devices (Auckland, N.Z.)
|January 29, 2025
概括
实施单一供应商的血液静止产品导致利益相关者的高满意度和显著的成本节省. 这一举措成功地降低了支出,而不会影响患者护理质量.
科学领域:
- 医疗保健管理的管理
- 手术供应链优化 手术供应链优化
- 卫生经济学 卫生经济学
背景情况:
- 医疗保健成本不断上升,需要在手术用品管理方面采取节省成本的举措.
- 对医院利益相关者实施此类节约成本策略的经验进行的研究有限.
- 了解利益相关者的观点对于成功的供应链转型至关重要.
研究的目的:
- 评估医院利益相关者对转换为血液静止产品的唯一供应商的满意度.
- 评估这种转换的经济和临床影响.
- 开发实施类似倡议的最佳实践.
主要方法:
- 美国一个学术医疗中心的横截面研究.
- 与临床和非临床利益相关者进行定性访谈和定量调查.
- 对外科手术期间出血事件,血压器利用率以及转换前后的支出进行分析.
主要成果:
- 报告的利益相关者满意度很高,75%的人对决策投入感到满意,100%的人对供应商支持的血液静止优化计划感到满意.
- 转换后的供应支出下降了近25%.
- 在术后出血事件中没有观察到任何显著变化,这表明维持了患者护理质量.
结论:
- 转换为血液静止产品的唯一供应商可以实现利益相关者的高满意度和显著的成本节省.
- 成功实施需要供应商,机构和医院利益相关者之间的有效协调.
- 这项研究为寻求优化静血产品管理的机构提供了一份路线图.
相关概念视频
Introduction to Hemostasis
5.2K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
5.2K
Extrinsic and Intrinsic Pathways of Hemostasis
5.0K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
5.0K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
602
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
602
Vascular Spasm
1.2K
The vascular phase, also known as vasospasm, is the initial stage of hemostasis, crucial for preventing excessive bleeding when a blood vessel is injured. After a vessel is cut, nerves in the damaged area trigger pain and other sensory impulses. Simultaneously, the smooth muscles in the vessel wall contract, resulting in a vascular spasm. This contraction reduces the vessel's diameter at the injury site, slowing or stopping blood loss through the vessel wall. Vascular spasms typically last...
1.2K


